IO Biotech (IOBT) Stock: Buy, Sell, or Hold?
$0.05
+0.02 (+48.61%)
▲
5d:
-75.13%
30d:
-85.27%
90d:
-92.85%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (75%)
Quality Score
47/100
Position
FAIR
Forward P/E & Valuation
-0.1x
Next 12M consensus est.
Wall Street Target
$2.18
+4441.7% upside
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$0.03 / $0.22
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: IOBT is down 75.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When IOBT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: IOBT is currently trading at $0.05, which is considered fair based on recent price action.
Technical Outlook: Technically, IOBT is in a strong downtrend. Immediate support is located at $0.03, while resistance sits at $0.22. The stock is showing strong short-term momentum, up 48.6% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $2.18 (+4441.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IOBT is in a strong downtrend. Immediate support is located at $0.03, while resistance sits at $0.22. The stock is showing strong short-term momentum, up 48.6% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $2.18 (+4441.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
47/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
74.7%
Trading Range & Key Levels
Support Level
$0.03
Resistance Level
$0.22
Current Trend
Strong Downtrend
Technical data as of
Apr 6, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: Strong upward momentum (+48.6%)
- BULLISH: Trading 4441.7% below Wall St target ($2.18)
- WARNING: Composite score 47/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.13
Wall Street Target
$2.18
(+4441.7%)
Share IOBT Analysis
Share this live IOBT analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (IOBT)
Bullish
18 Retail Mentions
StockTwits Volume
18 msgs
24h retail stream
Last Tracked
Apr 7, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits messages are overwhelmingly bullish towards $IOBT, with traders expressing optimism about potential gains and comparing it to other successful stocks. No newsworthy events or articles were identified.
Key Retail Themes:
Bullish sentiment towards $IOBT
Comparison to successful stocks
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 9:15 PM ET
Data refreshes hourly during market hours. Next update: 10:15 PM
Data refreshes hourly during market hours. Next update: 10:15 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IOBT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 52 HOLD |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 52 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 37 SELL |
|
ARWR
Arrowhead Pharmaceutical… |
STRONG BUY
15 analysts |
$108 | 50 HOLD |
|
ZYME
Zymeworks Inc. Common St… |
STRONG BUY
14 analysts |
$42 | 48 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive IOBT Research Pages
